Multiple Sclerosis
Feature
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
Latest News
Epstein-Barr virus a likely leading cause of multiple sclerosis
This study is the first to provide compelling evidence of a causal link between EBV and MS.
Supplements
Best of MS
Conference Recap
Highlights on DMT Use in Progressive MS From CMSC 2021
New data on DMT use in progressive MS presented at CMSC 2021 — including results from the ACAPELLA and EXPAND trials, and the novel agent ATA188...
Conference Recap
Update on Multiple Sclerosis Comorbidities From CMSC 2021
Key updates from CMSC 2021 on prevalent multiple sclerosis comorbidities including prevalence of hypertension, elevated BMI, depression, and...
Conference Coverage
B-cell repletion is common with MS drug, but no symptom worsening
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
Conference Coverage
Brief, automated cognitive test may offer key advantages in MS
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or...
Conference Coverage
Specialty pharmacists may speed time to MS treatment
Because there currently is no established DMT selection algorithm, specialty pharmacists can assist in medication education and management.